The US Drug Enforcement Administration is set to inspect the Kaiser Permanente pharmacy at Roseville Medical Center. The agency filed for an administrative inspection, which is the first inspection the facility has had in 11 years.
According to the affidavit filed, the pharmacy is the biggest purchaser of products for hydrocodone within the division. This division goes from the Oregon state line down to Bakersfield. Just in 2019 so far, it has bought almost 1.3 million doses of the drug, which is 250,000 more than the second place purchaser. It also is the third highest for oxycodone. Both of these drugs are highly addictive.
A spokesperson for Kaiser Permanente says that there is a logical reason for the high number. Because there are fewer locations for this pharmacy than for many smaller local pharmacies, they have a higher number of total prescriptions filled at one location. According to the spokesperson, the total volume of prescriptions filled is about 10 times what would be seen at an average pharmacy.
One of the primary concerns for the DEA, which prompted the inspection is what is known as drug diversion. This term describes what happens when a drug is diverted to someone other than who it is supposed to be prescribed for. Generally, this happens for illicit use.
A red flag noted was that prescriptions were filled for high dosages of these opioid pain medications for multiple patients over an extended time period. The DEA wants to verify that these prescriptions are legitimate.
According to the Kaiser spokesperson, the company has reduced the number of opioid prescriptions being given by almost 40 percent. It limits opioid prescriptions and offers other alternatives to pain management. The pharmacy says it does its part to work with doctors on prescribing lower doses of these medicines.
The warrant for inspection is administrative and not criminal. It provides a way for the DEA to inspect records and make copies. They can look at inventory records, order forms, invoices, reports and the list of workers who have access to any controlled substances. It could also include the list of patients who have a signed contract for opioid use.
Opioid use and abuse have been rising all over the country with many cities and regions facing an epidemic. While some of these opioids are illegal drugs, such as heroin, others are prescription opioids. Some of the most popular prescription drugs include morphine, hydrocodone and oxycodone. They all can lead to addiction if taken for too long or at too high doses.
Prescription medications can also lead to illicit drug use. It’s not uncommon for people to start with a prescription opioid and move on to an illicit opioid when they can’t get a prescription. Some people get the prescription to sell it on the street even if they aren’t taking it themselves. These drugs come at a much higher cost than heroin or other common street drugs.
Mixing drugs can be dangerous and even fatal, which is why opioid overdoses have become all too common. Agencies like the DEA want to make sure that pharmacies and doctors are doing their part to stop the epidemic and not encouraging it through irresponsible actions.
New Pill May Save Lives from Allergic Reactions
A group of medications which are used to treat blood cancers may also help those who suffer from life-threatening allergic reactions. These medications are known as BTK inhibitors, and they may help people with known drug and food allergies.
Hope for Allergy Sufferers
Researchers have been testing these drugs in lab experiments. They have determined that they may stop anaphylaxis. This is a condition which occurs when someone is exposed to a trigger food or other substance and develops a severe reaction. Symptoms of anaphylaxis include rapid heart rate, inability to breathe and dropping blood pressure. Insect stings, especially with bees, can also cause this condition.
According to the Asthma and Allergy Foundation of America, at least one in 50 suffer from this condition in America. It may be as high as one in 20. Currently, the main method of treatment for these people is avoidance. It can be a bit tricky for those with certain types of allergies, such as an allergy to peanuts. Palforzia is a medication which as recently been approved by the FDA to help children avoid severe reactions from peanuts.
Allergy shots are also given to prevent anaphylaxis from allergy triggers, especially insect stings. While these treatments can be quite effective, they are limited to a specific type of allergy.
BTK inhibitors would cover a broad spectrum of allergies. If they work for these situations, they wouldn’t depend on the type of allergy. BTK inhibitors block the enzyme which sets off the reactions to allergens.
Studies on BTK Inhibitors and Allergies
The tests used lab mice and showed that three different inhibitors blocked the responses to allergens. These tests follow two other small studies that were conducted on humans. One study focused on cancer patients. It found that those who were taking Imbruvica had less of a response to pollen and cat dander when they were exposed.
The second study showed that people who were given this medication had a lower reactivity when given standard allergy skin tests after just a few days of taking Imbruvica or ibrutinib.
While these results are promising, doctors recommend caution. There is concern for side effects with the medications. Some of these side effects which are currently known are a drop in white blood cell counts and pneumonia. The drugs haven’t been approved for use in children.
If the medications are effective against food allergies, they would have to be taken on a regular basis. It’s often difficult to predict or detect exposure to certain foods, which can be accidental.
Another concern is with the cost of the medication, which is currently at $15,000 for a single month’s supply. This steep price tag puts them out of reach for most people who suffer from allergies.
Even though test results are promising, critics remain cautious. However, they do agree that more testing is worthwhile. Allergic reactions are common and those that are life-threatening can happen quickly with no notice. Until a drug is determined to be effective, patients must remain diligent about exposure to allergy triggers.
A Drug May Reduce Risk of Brain Injury
A study has discovered that a drug may reduce the risk for traumatic brain injury after an accident, such as a car crash. The drug would be given within a few hours of the trauma.
Medication to Treat Brain Injury
Clinical trials were conducted in London with a tranexamic acid (TXA), which prevents the breakdown of blood clots. The result is that it would prevent blood from getting into the brain, which occurs in a TBI or trauma to the brain. The study was quite large with 12,000 patients either receiving TXA intravenously or a placebo. They were located in 29 countries at just under 200 different hospitals.
The results showed that patients who were given the medication within three hours of the trauma lowered their risk of death. The best results were seen in those with either mild or moderate brain injury. There was no significant improvement seen in patients with severe brain trauma.
No harmful side effects were noted and no more disability in those who received the medication. TXA has already been recognized for its benefits with chest and abdomen wounds. The researchers noted that TXA can’t repair any damage that is done in a traumatic brain injury, so time is of the essence. The study showed that the effectiveness of TXA was reduced by about ten percent for every 20 minutes that went by without treatment.
What Causes TBI?
Traumatic brain injury is caused by severe trauma to the brain from an outside force. In a car accident, the person may hit their head on the windshield or other part of a car. It can cause them to lose consciousness, but that is not always the case. In some instances, a person can have a TBI and not realize it.
Other symptoms of a TBI include blurred vision, headaches and tiredness, problems remembering things, and vomiting. The symptoms can show up right away or be delayed for a few days. The loss of consciousness can happen for just a few seconds or longer.
The problem with traumatic brain injury is that many people may not realize they aren’t well if their other injuries have healed. TBI can last for days, weeks or even years. It may cause permanent damage to the brain. While severe brain trauma will be evident right away, mild trauma may not be diagnosed immediately. And even though it may not lead to death, it can have a severe impact on the quality of life for the person. They may no longer be able to do the same things as before or require more help with activities.
The impact of a TBI is more than just mental. They may lose the ability to function in other ways, depending on the area of the brain that was damaged. It can impact speech, thinking and even physical movements.
It is critical to get treatment as early as possible after an injury to the brain. Even if you feel fine after a car accident or other incident, you should get checked out. You don’t want to wait until symptoms show up hours or days later. By then, you could have suffered permanent injury.
Massachusetts Department of Public Health Says Leading Cause of Workplace Deaths is Opioids
According to the Massachusetts Department of Public Health, the leading cause of deaths at work is opioid overdoses. The report showed that 220 deaths occurred at a workplace in 2017. Of those, one-fourth were from accidental overdoses of opioids.
The most common industries to see this issue was in food service, accommodation construction and real estate. The number of deaths from opioid overdose has tripled from 2011 to 2016. The average age of those who died was 39.
Next to overdoses, falls, car crashes and suicide were the most common causes of death in the workplace. Workers being hit by a vehicle was also on the list. Almost all of the victims are male at an astonishing 90 percent. Almost 80 percent were non-Hispanic whites.
The rate of deaths in the workplace has increased in general. It went from 1.9 per 100,000 from 2013 to 3.3 in 2017. This only includes full-time workers and not part-time or temporary hires.
Understanding Opioid Overdose
Opioids are often prescribed as painkillers for an injury or medical condition. They are generally meant to be short-term, but some people continue taking them for longer. The risk for dependency goes up with long-term use.
The most common way for a person to overdose on opioids is by mixing them with other drugs or taking them for longer than what is necessary. This situation can happen at work if the person is hurting from the job and takes more pills or a different pain pill after taking their opioid prescription. Sometimes, a person can give one of their prescription medications to someone who has been hurt or is complaining of pain. They may think it will help, not realizing the risk that comes from taking a prescription that isn’t yours.
What an Overdose Looks Like
An overdose can cause a seizure. A person may aspirate on their vomit when they have taken too much of the medication. The medication can slow down breathing to the point that they aren’t getting enough oxygen, which causes respiratory depression. If it continues, the person will die because the brain and other organs didn’t get enough oxygen to function.
If someone is overdosing on opioid medication, time is critical. Emergency help needs to be contacted right away. They may have a medication called Narcan that will stop the effects of the opioid until the person reaches the hospital.
Employers need to be aware of the risk for overdose with their employees. A person doesn’t need to be a drug addict to be more likely to overdose on opioids. If they mix their prescription medication with other medicines or take more than the prescribed amount, they could become the victim of an overdose. Employers can teach their workers about the dangers of overdose in employee training. It’s also helpful to teach them what an overdose looks like, so they are better equipped to respond in an emergency if it should happen in the workplace.
Medical Devices1 year ago
Complications from Hernia Mesh
Defective Products6 months ago
Vaping Doesn’t Replace Smoking
Defective Products7 months ago
Toyota Has More Safety Recalls
Covid-192 months ago
Results from Remdesivir Clinical Trial to Come Soon
Covid-193 months ago
Anti-parasite Drug Being Tested for Use Against COVID-19
Defective Products1 month ago
Baby and Toddler Swing Recalled for Fall Hazard
Defective Products1 month ago
Ford Issues New Recall
Prescription Drugs3 months ago
FDA Orders Zantac Pulled from the Market